Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

Bora Pharmaceuticals Co., LTD. (6472.TW)

Compare
692.00
-6.00
(-0.86%)
At close: April 2 at 1:30:33 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Pao-Shi Sheng Chairman, GM & CEO -- -- --
Ms. Alice Wang CFO of HQ & APAC -- -- --
Ms. Ellen Chen Corporate Human Resource Director -- -- --
Mr. Shih-Min Chen VP & Director -- -- --
Ms. Sally Langa Senior VP of Marketing and Sales - CDMO Business -- -- --
Mr. Marcel Vieno CFO of North America -- -- --
Tom Chang Senior Vice President of Taiwan Site Operations -- -- --
Xiu-Rong Zhang Deputy General Manager -- -- --
Zhen-Tang Zhang Deputy General Manager -- -- --

Bora Pharmaceuticals Co., LTD.

No. 2, Ruiguang Road
6th Floor Aly. 36, Ln. 26 Neihu District
Taipei, 114
Taiwan
886 2 2790 1555 https://www.bora-corp.com
Sector: 
Healthcare

Description

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services. In addition, it provides food and vitamin supplements, and skincare products; and biotechnical services. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei City, Taiwan.

Corporate Governance

Bora Pharmaceuticals Co., LTD.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 5, 2025 at 10:59 AM UTC - May 9, 2025 at 12:00 PM UTC

Bora Pharmaceuticals Co., LTD. Earnings Date

Recent Events

August 12, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers